Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT02187913
Other study ID # 1406014929
Secondary ID
Status Unknown status
Phase N/A
First received July 9, 2014
Last updated July 10, 2014
Start date July 2014

Study information

Verified date July 2014
Source Purdue University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

- About two-thirds of adults in the United States are overweight or obese which can cause adverse health consequences for those individuals. Post-prandial hyperglycemia is one of these possible consequences and is associated with a higher risk for Type 2 Diabetes. Controlling hyperglycemia is important in the prevention of the onset of diabetes and obesity. Resistant starch is a dietary carbohydrate which is not completely digested in the gut and produces energy for the body to use. The investigators are interested in assessing the effects of resistant starch on postprandial blood glucose and insulin concentrations.

- Aim: To assess the effects of a resistant starch on post-prandial blood glucose and insulin concentrations.

- Hypothesis: A baked snack bar with a resistant starch will blunt and sustain the post-prandial rise in blood glucose and insulin concentrations compared to a baked snack bar with maltodextrin (an easily digested carbohydrate).


Recruitment information / eligibility

Status Unknown status
Enrollment 20
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria:

- Thirty healthy men and women (aged 18-29y) will be recruited from the greater Lafayette, IN region with the expectation that =20 subjects will complete the study. Subjects must weigh >110 pounds, with a BMI between 20.0 and 29.9.

Exclusion Criteria:

- Weight change > 3kg in the past 3 months

- Exercising vigorously over the past 3 months as well as no exercise 3 days prior to testing day

- Intestinal disorders including lipid mal-absorption or lactose intolerance

- Abnormal liver or kidney function tests; fasting blood glucose >100mg/dL

- Smoking

- Drinking more than 2 alcoholic drinks per day

- Taking lipid-lowering medications or dietary supplements affecting plasma cholesterol concentration.

- Subjects must not be pregnant or lactating.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Resistant starch
Each subject will complete 2 testing days (randomized and crossover design). On each of 2 test days, subjects will arrive at the Purdue Clinical Research Center after a 12-h fast and will consume a snack bar containing resistant starch. The test snack bar will be consumed along with a standard meal provided at the start of the test day. A second standard meal that does not contain the snack bar will be consumed four hours later.

Locations

Country Name City State
United States Purdue University West Lafayette Indiana

Sponsors (1)

Lead Sponsor Collaborator
Purdue University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary resistant starch effects effects of resistant starch consumption of area under the curve of blood serum glucose, insulin, and hydrogen breath testing 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT02161250 - Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses N/A